✦ LIBER ✦

DOP063 Biomarker panel for prediction of mucosal healing in patients with Crohn's disease under infliximab therapy

✍ Scribed by de Bruyn, M.; Bessissow, T.; Billiet, T.; Cleynen, I.; Kirkland, R.; Liu, X.; Hauenstein, S.; Drake, K.; Singh, S.; Ferrante, M.; Rutgeerts, P.; Van Assche, G.; Arijs, I.; Opdenakker, G.; Vermeire, S.

Book ID: 122159435
Publisher: Oxford University Press
Year: 2014
Tongue: English
Weight: 103 KB
Volume: 8
Category: Article
ISSN: 1873-9946
DOI: 10.1016/S1873-9946(14)60088-X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Su1292 Biomarker Panel for Prediction of

Su1292 Biomarker Panel for Prediction of Mucosal Healing in Patients With Crohn's Disease Under Infliximab Therapy

✍ de Bruyn, Magali; Bessissow, Talat; Billiet, Thomas; Cleynen, Isabelle; Kirkland 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 488 KB

Mucosal healing predicts long-term outco

Mucosal healing predicts long-term outcome of maintenance therapy with infliximab in Crohn's disease

✍ Fabian Schnitzler; Herma Fidder; Marc Ferrante; Maja Noman; Ingrid Arijs; Gert V 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 395 KB 👁 2 views

Background: Infliximab (IFX) treatment induces mucosal healing (MH) in patients with Crohn's disease (CD) but the impact of MH on the long-term outcome of IFX treatment in CD is still debated. ## Methods: We studied MH during long-term treatment with IFX in 214 CD patients. A total of 183 patients

1027 A Single Biomarker Panel Predicts R

1027 A Single Biomarker Panel Predicts Response to Infliximab in Patients With Crohn's Disease and Ulcerative Colitis

✍ Westra, Willem; Hoang, Vy; Laifenfeld, Daphna 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 344 KB

DOP061 Pharmacokinetic considerations fo

DOP061 Pharmacokinetic considerations for optimising dosing regimens of infliximab in patients with Crohn's disease

✍ Andersson, H.; Keunecke, A.; Eser, A.; Huisinga, W.; Reinisch, W.; Kloft, C. 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 159 KB

Profiles of circulating cytokines in pat

Profiles of circulating cytokines in patients with Crohn's disease under maintenance therapy with infliximab

✍ Kotaro Ogawa; Takayuki Matsumoto; Motohiro Esaki; Takehiro Torisu; Mitsuo Iida 📂 Article 📅 2012 🏛 Oxford University Press 🌐 English ⚖ 421 KB

Mo1413 Improved Mucosal Healing During I

Mo1413 Improved Mucosal Healing During Infliximab Maintenance Therapy Initiated Following Resection of Active Lesions in Crohn's Disease Patients

✍ Yasuo Suzuki; Akihiro Yamada 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 74 KB